Crystal McGuire
Family · Bamberg, SCNPI 1255082368
Payments from drug & device makers
Across 357 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$920
- Lilly USA, LLC$722
- AstraZeneca$681
- Novartis$371
- Esperion Therapeutics, Inc.$325
- Bayer$295
- plus $3K from 28 others
What the payments were for
- Food & beverage$5,815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $920 |
| Lilly USA, LLC | 42 | $722 |
| AstraZeneca | 32 | $681 |
| Novartis | 20 | $371 |
| Esperion Therapeutics, Inc. | 20 | $325 |
| Bayer | 15 | $295 |
| Novo Nordisk | 13 | $274 |
| GSK | 14 | $214 |
| Pfizer | 12 | $202 |
| Boehringer Ingelheim | 9 | $183 |
| Supernus Pharmaceuticals, Inc. | 1 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $151 |
| Xeris Pharmaceuticals, Inc. | 7 | $138 |
| Axsome Therapeutics, Inc. | 5 | $115 |
| Merck | 7 | $109 |
| Collegium Pharmaceutical, Inc. | 6 | $100 |
| Amgen | 5 | $99 |
| Sanofi-aventis U.S. LLC | 4 | $67 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Ironshore Pharmaceuticals Inc. | 3 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Corium, LLC | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Exact Sciences | 3 | $46 |
| Viatris Specialty LLC | 2 | $46 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Boston Scientific | 1 | $44 |
| Corcept Therapeutics | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 3 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Organon | 2 | $24 |
| Amarin Pharma, Inc. | 1 | $21 |
| VBI Vaccine (delaware) Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,815 in reported general payments places this provider in the 90th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 177 | $115,598 |
| OzempicSemaglutide | 71 | $81,805 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 63 | $61,495 |
| MounjaroTirzepatide | 31 | $31,640 |
| JardianceEmpagliflozin | 28 | $22,097 |
| TrulicityDulaglutide | 13 | $21,982 |
| EliquisApixaban | 21 | $19,149 |
| KerendiaFinerenone | 24 | $17,788 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 15 | $14,974 |
| RybelsusSemaglutide | 13 | $14,778 |
| MyrbetriqMirabegron | 21 | $12,925 |
| JanuviaSitagliptin Phosphate | 15 | $12,091 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 17 | $9,892 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $8,796 |
| EntrestoSacubitril/Valsartan | 12 | $8,686 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Symbicort | $681 | $124,394199 claims |
| Novo NordiskOzempic, Rybelsus | $274 | $96,58384 claims |
| GSKTrelegy Ellipta | $214 | $61,49563 claims |
| Lilly USA, LLCMounjaro, Trulicity | $722 | $53,62244 claims |
| Boehringer IngelheimJardiance | $183 | $22,09728 claims |
| MerckJanuvia, Janumet Xr | $109 | $21,98432 claims |
| PfizerEliquis | $202 | $19,14921 claims |
| BayerKerendia | $295 | $17,78824 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $67 | $14,97415 claims |
| NovartisEntresto | $371 | $8,68612 claims |
| AbbVieLinzess | $920 | $7,42011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,248 family providers in South Carolina.
Other family in Bamberg
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.